Recommended Pages at rituxan.com
Important Safety Information
rituxan.com — “Important Safety Information about RITUXAN. Indications and Important Safety Information RITUXAN® (Rituximab) is indicated for the treatment of patients with: Relapsed or refractory, low-grade or follicular, CD20-positive, B-cell NHL as a single agent, Previously untreated follicular, CD20-positive, B-cell NHL in combination with CVP chemotherapy and, in patients achieving a complete or partial response to RITUXAN in combination with chemotherapy, as single-agent maintenance therapy, Non-pr” View full resource at rituxan.com
Most Recently Shared on March 10, 2012 at 11:42 pm By:
What Should You Know About RITUXAN? http://t.co/w8NMjshM Be careful joining clinical trials with this drug #diabetes
Rituxan (Rituximab) for Rheumatoid Arthritis and Non-Hodgkins Lymphoma
rituxan.com — “Rituxan (Rituximab) is a unique therapy that works by selectively depleting CD20+ B-cells. B-cells, and their role in cancer and autoimmune diseases, have been an area of intensive research by scientists around the world, and at Genentech and Biogen Idec. Rituxan affects your immune system by selectively targeting CD20+ B-cells shown to play an important role in non-Hodgkin's lymphoma and rheumatoid arthritis.” View full resource at rituxan.com
Most Recently Shared on November 11, 2009 at 3:21 am By:
Rituxan generally indicated for RA when when the use of 1+TNF antagonist drug response is inadequate http://www.rituxan.com/
